Growth Metrics

Ultragenyx Pharmaceutical (RARE) Enterprise Value Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Ultragenyx Pharmaceutical 2.29 Bn 1.89 Bn 106.00 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 16.70%
Dec 31, 2025 -11.61%
Sep 30, 2025 31.95%
Jun 30, 2025 37.08%
Mar 31, 2025 -18.27%
Dec 31, 2024 -4.39%
Sep 30, 2024 -39.02%
Jun 30, 2024 -38.38%
Mar 31, 2024 34.52%
Dec 31, 2023 22.75%
Sep 30, 2023 50.25%
Jun 30, 2023 -1.69%
Mar 31, 2023 -5.19%
Dec 31, 2022 -1.02%
Sep 30, 2022 -20.56%
Jun 30, 2022 35.82%
Mar 31, 2022 38.02%
Dec 31, 2021 38.40%
Sep 30, 2021 3.71%
Jun 30, 2021 -151.98%
Mar 31, 2021 -45.55%
Dec 31, 2020 -59.09%
Sep 30, 2020 -45.24%
Jun 30, 2020 45.71%
Mar 31, 2020 7.27%
Dec 31, 2019 -64.29%
Sep 30, 2019 -4.76%
Jun 30, 2019 -13.00%
Mar 31, 2019 -32.14%
Dec 31, 2018 -96.04%
Sep 30, 2018 -35.58%
Jun 30, 2018 -36.90%
Mar 31, 2018 -27.32%
Dec 31, 2017 38.32%
Sep 30, 2017 6.40%
Jun 30, 2017 -2.00%
Mar 31, 2017 -3.24%
Dec 31, 2016 13.01%
Sep 30, 2016 11.59%
Jun 30, 2016 -20.17%
Mar 31, 2016 -20.23%
Dec 31, 2015 -133.08%
Sep 30, 2015 -122.86%
Jun 30, 2015 -112.71%
Mar 31, 2015 -107.12%
Dec 31, 2014 -7,790.87%
Sep 30, 2014 -3,226.07%
Jun 30, 2014 -1,034.75%
Mar 31, 2014 -155.25%